Water

Water

SCHEMBL1726469

NCCCCCCN.O.O

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 1/20 0.57
DNM1 Q05193 9/20 0.89
CA12 O43570 2/20 0.89
CA1 P00915 2/20 0.89
CA2 P00918 2/20 0.89
CA3 P07451 2/20 0.89
CA4 P22748 2/20 0.89
CA6 P23280 2/20 0.89
CA5A P35218 2/20 0.89
CA7 P43166 2/20 0.89
CA9 Q16790 2/20 0.89
CA14 Q9ULX7 2/20 0.89
CA5B Q9Y2D0 2/20 0.89
TSHR P16473 2/20 0.89
LMNA P02545 1/20 0.89
BLM P54132 1/20 0.89
NFKB1 P19838 1/20 0.78
KMT2A Q03164 1/20 0.57
ALDH1A1 P00352 1/20 0.57
EPHX1 P07099 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL28172776 1.00 DNM1 (0.89) DNM1CA12CA1CA2CA3
Water SCHEMBL31147094 1.00 DNM1 (0.89) DNM1CA12CA1CA2CA3
Water SCHEMBL27506242 1.00 DNM1 (0.89) DNM1CA12CA1CA2CA3
Water SCHEMBL27567442 1.00 DNM1 (0.89) DNM1CA12CA1CA2CA3
Water SCHEMBL5492049 1.00
Water SCHEMBL27524665 0.95 DNM1 (0.80) DNM1CA12CA1CA2CA3
Water SCHEMBL15710762 0.95 DNM1 (0.80) DNM1CA12CA1CA2CA3
Hydrochloric Acid SCHEMBL28962554 0.95 DNM1 (0.80) DNM1CA12CA1CA2CA3
SCHEMBL25262966 0.94 DNM1 (1.00) DNM1CA12CA1CA2CA3
SCHEMBL22684930 0.94 DNM1 (1.00) DNM1CA12CA1CA2CA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119750607-A Nano rod-shaped ZSM-48 molecular sieve, preparation method thereof, hydroisomerization catalyst and application thereof 国家能源集团宁夏煤业有限责任公司 2025-04-04 CN claimed
CN-119750607-A Nano rod-shaped ZSM-48 molecular sieve, preparation method thereof, hydroisomerization catalyst and application thereof 国家能源集团宁夏煤业有限责任公司 2025-04-04 CN disclosed
CN-112585092-B Molecular sieve and method for manufacturing molecular sieve 埃克森美孚科技工程公司 2025-03-04 CN disclosed
EP-3545958-B1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF ESSENTIALIS INC (US) 2024-07-10 EP disclosed
CN-117583020-A Zeolite having improved hydroisomerization reactivity SK新技术株式会社 2024-02-23 CN disclosed
CN-113603108-B O-Si-Al-Zr ternary framework AEI molecular sieve and synthesis method thereof 威海佰德信新材料有限公司 2024-01-30 CN disclosed
US-11786536-B2 Salts of potassium ATP channel openers and uses thereof ESSENTIALIS, INC. (US) 2023-10-17 US disclosed
CN-113860327-B ERI type magnesium-silicon-aluminum molecular sieve, synthesis method and application thereof 中国石油化工股份有限公司 2023-07-04 CN disclosed
US-20220047605-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF SOLENO THERAPEUTICS, INC. 2022-02-17 US disclosed
CN-108602052-B High charge density metal phosphate molecular sieves 环球油品公司 2021-11-26 CN disclosed
US-20090148526-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF ESSENTIALIS, INC. 2009-06-11 US disclosed
US-20090062264-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF SOLENO THERAPEUTICS, INC. 2009-03-05 US disclosed
EP-1968601-A4 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF ESSENTIALIS INC (US) 2009-02-25 EP disclosed
WO-2009006483-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF ESSENTIALIS, INC. (US) 2009-01-08 WO disclosed
EP-1968601-A2 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF Essentialis, Inc. (US) 2008-09-17 EP disclosed
US-20070191351-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF SOLENO THERAPEUTICS, INC. 2007-08-16 US disclosed
WO-2007081521-A2 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF ESSENTIALIS, INC. (US) 2007-07-19 WO disclosed
CN-1291914-C Synthetic porous crystalline material ITQ-13, its synthesis and use EXXONMOBIL RES & ENG CO (US) 2006-12-27 CN disclosed
CN-1512965-A Synthetic porous crystalline mateial ITQ-3, its synthesis and use ����ɭ�о����̹�˾ 2004-07-14 CN disclosed
US-5623088-A TETRASUBSTITUTED AMMONIUM SALT CHEMICAL INTERMEDIATES OBTAINED FROM REACTING NITROBENZENE, ANILINE IN PRESENCE OF A BASE; HALOGEN-FREE PROCESS FLEXSYS AMERICA L. P. (US) 1997-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220047605-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF KCNJ1, KCNJ11, KCNJ2 MEN1 1436/4885DNM1 967/4885CA12 4541/4885
US-20070191351-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF KCNJ1, KCNJ11, KCNJ2 MEN1 1436/4885DNM1 967/4885CA12 4541/4885
US-20090062264-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF KCNJ1, KCNJ11, KCNJ2 MEN1 1436/4885DNM1 967/4885CA12 4541/4885
US-11786536-B2 Salts of potassium ATP channel openers and uses thereof KCNJ1, KCNJ11, KCNJ2 MEN1 1436/4885DNM1 967/4885CA12 4541/4885
US-20090148526-A1 SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF KCNJ1, KCNJ11, KCNJ2 MEN1 1436/4885DNM1 967/4885CA12 4541/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.